Fidelity Investments’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Fidelity Investments’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,727,521	Closed	-$360M	–	2786
2016 Q1	$360M	Buy	6,727,521 +110,186	+2%	+$8.13M	0.05%	398
2015 Q4	$748M	Buy	6,617,335 +2,710,541	+69%	+$299M	0.1%	207
2015 Q3	$460M	Buy	3,906,794 +586,300	+18%	+$76.6M	0.07%	326
2015 Q2	$257M	Buy	3,320,494 +1,211,445	+57%	+$79.4M	0.03%	566
2015 Q1	$122M	Buy	2,109,049 +748,134	+55%	+$31.8M	0.02%	940
2014 Q4	$43.9M	Buy	1,360,915 +211,499	+18%	+$6.35M	0.01%	1386
2014 Q3	$28.1M	Hold	1,149,416	–	–	﹤0.01%	1587
2014 Q2	$20.4M	Buy	1,149,416 +633,700	+123%	+$10.2M	﹤0.01%	1791
2014 Q1	$10.3M	Buy	515,716 +415,716	+416%	+$8.06M	﹤0.01%	2008
2013 Q4	$1.68M	Buy	+100,000	New	+$1.38M	﹤0.01%	2384

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Fidelity Investments's ANAC Position: Q2 2016 in Review

Fidelity Investments sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 6,727,521 shares — an estimated $360M sold.

Fidelity Investments first reported a position in ANAC in Q4 2013 and held it in 10 quarters. The position peaked at $748M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Fidelity Investments reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Fidelity Investments sold 6,727,521 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $360M.
Fidelity Investments first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 10 quarters.
Fidelity Investments's ANACOR PHARMACEUTICALS INC COM position peaked at $748M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Fidelity Investments's 13F filing for Q2 2016, filed 11 Aug 2016.